Tahereh Yavari: DOACs vs Warfarin in Antiphospholipid Syndrome
Tahereh Yavari, Assistant Professor at Tehran University of Medical Sciences, shared a post on LinkedIn about a paper by Alessandra Ida Celia et al. published in Seminars in Arthritis and Rheumatism:
“DOACs vs Warfarin in Antiphospholipid Syndrome: What Does the Evidence Say in 2025?
A major new systematic review and meta-analysis by Alessandra Ida Celia, Giovanni Maria Vescovo, Cristiano Alessandri, Fabrizio Conti, Behnood Bikdeli, Michelle Petri, Andrea Fava, Mattia Galli published in Seminars in Arthritis and Rheumatism (2025), sheds new light on one of the most debated clinical questions in APS management.
The Numbers Tell the Story
Across 12 studies (4 RCTs + 8 observational; 1,307 patients)
- Composite thrombotic events were > 2× higher with DOACs vs VKAs – IRR 2.33 (95 % CI 1.18 – 4.58)
- Arterial thrombosis risk tripled – IRR 2.70 (1.42 – 5.13)
- Venous thrombosis: no significant difference – IRR 0.98 (0.59 – 1.64)
- Major bleeding: similar between groups – IRR 0.83 (0.48 – 1.43)
Interestingly, in a small subgroup, combining DOACs + a single antiplatelet agent seemed to mitigate arterial risk — a hypothesis that calls for future trials.
Clinical Message
Despite their convenience, DOACs may not be safe in high-risk APS, especially in patients with arterial events or triple-positive profiles.
Warfarin remains the gold standard.
The findings emphasize the need for precision anticoagulation strategies and better biomarkers to guide therapy in APS.
This meta-analysis reinforces the critical message: not all thromboses are the same, and not all anticoagulants are interchangeable.”
Title: Direct oral anticoagulants versus Vitamin K antagonists in antiphospholipid syndrome: A systematic review and meta-analysis
Authors: Alessandra Ida Celia, Giovanni Maria Vescovo, Gianmarco Sarto, Cristiano Alessandri, Antonio Iaconelli, Domenico D’Amario, Giacomo Frati, Fabrizio Conti, Sebastiano Sciarretta, Dominick J. Angiolillo, Andrea Fava, Michelle A. Petri, Behnood Bikdeli, Mattia Galli
Read the full article.

Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Nov 12, 2026, 18:26Jakub Dejewski: IVF Turns 49, We’re Making It with 49 More Families
-
Nov 12, 2026, 18:16Svitlana Popkova: What IVF Should Feel Like
-
Nov 12, 2026, 18:10Caspian Ostadian: How Long Should an Embryo Rest After Warming Before Transfer?
-
Nov 12, 2026, 18:03Fereshteh Safian: Pleased to Participate in the 24th International Congress of the Iranian Society for Reproductive Medicine
-
Nov 12, 2026, 17:54Zuzana Holubcova: Assisted Reproduction Community Comes Together at 36th Congress
-
Nov 12, 2026, 17:47Mark Amols: 3 Trials, 3 Different Patients – IUI or IVF First?
-
Nov 12, 2026, 17:44Nearly 1 in 5 Women Surveyed Have Experienced Infertility – IVI Institute
-
Nov 12, 2026, 17:40Kate Ryder: Maven Care Is Now In-Network with More Than 475 Health Plans
-
Nov 12, 2026, 17:37Diana Kayal: Speaking About Trauma and Fertility at the 3rd International Conference on Gynecology and Women’s Health
